Mouse models. Psoriasis: An epidermal disease after all?

European Journal of Human Genetics

Volumn 14, Issue 1, 2006, Pages 2-4

  Gudjonsson, Johann E ^a   Elder, James T ^a,b,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; CYTOKINE RECEPTOR ANTAGONIST; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PROTEIN C JUN; PROTEIN FOS; PROTEIN P16INK4A; PROTEIN P53; PROTEIN S 100; RAG2 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; DRUG EFFICACY; EPIDERMIS CELL; EPIDERMIS HYPERPLASIA; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; LYMPHOCYTE FUNCTION; MULTIFACTORIAL INHERITANCE; NONHUMAN; NOTE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; PSORIATIC ARTHRITIS; SKIN BLOOD FLOW; T LYMPHOCYTE;

ANIMALS; CALGRANULIN A; CALGRANULIN B; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENES, JUN; HUMANS; MICE; MICE, KNOCKOUT; PSORIASIS; T-LYMPHOCYTES;

EID: 29644433354     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201543     Document Type: Note

References (18)

1. Zenz R, Eferl R, Kenner L et al: Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005; 437: 369-375.
2. Krueger JG, Bowcock AC Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64 (Suppl 2): Ii30-ii36.
3. Rahman P, Elder JT: Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005; 64 (Suppl 2): Ii37-ii39; discussion ii40-ii31.
4. Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Voorhees JJ: The genetics of psoriasis. Arch Dermatol 1994; 130: 216-224.
5. Stuart PE, Nair RP, Abecasis G et al: Lack of evidence for association between psoriasis and polymorphisms of a RUNX1 binding site and the RAPTOR gene on distal chromosome 17q, despite adequate power and evidence for linkage. J Med Genet 2005, doi:10.1136/jmg.2005.032193.
6. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H: Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004; 135: 1-8.
7. Gardembas-Pain M, Ifrah N, Foussard C, Boasson M, Saint Andre JP, Verret JL: Psoriasis after allogeneic bone marrow transplantation [letter]. Arch Dermatol 1990; 126: 1523.
8. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO: Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 2004; 199: 731-736.
9. Jochum W, Passegue E, Wagner EF: AP-1 in mouse development and tumorigenesis. Oncogene 2001; 20: 2401-2412.
10. Weitzman JB: Life and death in the JUNgle. Trends Mol Med 2001; 7: 141-142.
11. Szabowski A, Maas-Szabowski N, Andrecht S et al: C-Jun and JunB antagonistically control cytokine-regulated mesenchymalepidermal interaction in skin. Cell 2000; 103: 745-755.
12. Jackson B, Tilli CL, Hardman M et al: Late cornified envelope family in differentiating epithelia - response to calcium and ultraviolet irradiation. J Invest Dermatol 2005; 124: 1062-1070.
13. Hardas BD, Zhao X, Zhang J, Longqing X, Stoll S, Elder JT: Assignment of psoriasin to human chromosomal band 1q21: Coordinate overexpression of clustered genes in psoriasis. J Invest Dermatol 1996; 106: 753-758.
14. Bowcock AM, KruegeT JG: Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 2005; 5: 699-711.
15. Piskin G, Tursen U, Sylva-Steenland RM, Bos JD, Teunissen MB: Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers - IL-12, IL-18 and IL-23. Exp Dermatol 2004; 13: 764-772.
16. Mansbridge JN, Knapp AM, Strefling AM: Evidence for an alternative pathway of keratinocyte maturation in psoriasis from an antigen found in psoriatic but not normal epidermis. J Invest Dermatol 1984; 83: 296-301.
17. Thorn T, Gniadecki R, Petersen AB, Vicanova J, Wulf HC: Differences in activation of G2/M checkpoint in keratinocytes after genotoxic stress induced by hydrogen peroxide and ultraviolet A radiation. Free Rad Res 2001; 35: 405-416.
18. Johansen C, Kragballe K, Rasmussen M, Dam TN, Iversen L: Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin. Br J Dermatol 2004; 151: 600-607.